Zealand Pharma A/S (LON:0NZU)
London · Delayed Price · Currency is GBP · Price in DKK 410.00
-0.50 (-0.12%)
At close: Jan 13, 2026
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 3.33 billion as of January 16, 2026. Its market cap has decreased by -41.26% in one year.
Market Cap
3.33B
Enterprise Value
1.50B
Revenue
1.07B
Ranking
n/a
PE Ratio
4.35
Stock Price
410.00
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 159.84M to 3.33B, an increase of 1,982.60%. That is a compound annual growth rate of 22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 3.33B | -13.32% |
| Dec 30, 2025 | 3.84B | -31.68% |
| Dec 30, 2024 | 5.62B | 121.65% |
| Dec 29, 2023 | 2.54B | 105.19% |
| Dec 30, 2022 | 1.24B | 74.70% |
| Dec 30, 2021 | 707.55M | -33.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 222.49B |
| HSBC Holdings | 207.99B |
| Shell | 156.28B |
| Unilever | 106.98B |
| Rio Tinto Group | 106.77B |
| Rolls-Royce Holdings | 106.64B |
| British American Tobacco p.l.c. | 92.08B |
| GSK plc | 75.45B |